Home > Insider Trading > Filing (0001179110-14-001313)

Filing Details

Accession Number:: 0001179110-14-001313
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-23 17:01:10
Reporting Period:: 2014-01-21

Filing Date:: 2014-01-23
Accepted Time:: 2014-01-23 17:01:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1113481	Medicines Co	MDCO	Pharmaceutical Preparations (2834)	043324394

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1318459	Michael Paul Antinori	8 Sylvan Way Parsippany NJ 07054	Sr. Vp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-01-21	10,500	$7.31	41,912	No	4	M	Direct
Common Stock	Disposition	2014-01-21	10,500	$38.00	31,412	No	4	S	Direct
Common Stock	Acquisiton	2014-01-21	20,000	$14.82	51,412	No	4	M	Direct
Common Stock	Disposition	2014-01-21	20,000	$38.09	31,412	No	4	S	Direct
Common Stock	Acquisiton	2014-01-21	7,000	$17.45	38,412	No	4	M	Direct
Common Stock	Disposition	2014-01-21	7,000	$37.82	31,412	No	4	S	Direct
Common Stock	Disposition	2014-01-21	383	$38.05	31,029	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right-to-buy)	Disposition	2014-01-21	10,500	$0.00	10,500	$7.31
Common Stock	Stock Option (right-to-buy)	Disposition	2014-01-21	20,000	$0.00	20,000	$14.82
Common Stock	Stock Option (right-to-buy)	Disposition	2014-01-21	7,000	$0.00	7,000	$17.45

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,000	2020-02-19	No	4	M	Direct
8,330	2020-09-17	No	4	M	Direct
6,333	2021-02-18	No	4	M	Direct

Footnotes

The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on December 13, 2013.
Represents the weighted average sales price of the shares sold ranging from a low of $37.77 to a high of $38.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $37.72 to a high of $38.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $37.70 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $38.05 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option vests in forty-eight equal monthly installments beginning on March 19, 2010.
This option vests in forty-eight equal monthly installments beginning October 17, 2010.
This option vests in forty-eight equal monthly installments beginning on March 18, 2011.
Not applicable.